Genotypic Methods for HIV Drug Resistance Monitoring: the Opportunities and Challenges Faced by China.

Genotypic Methods for HIV Drug Resistance Monitoring: the Opportunities and Challenges Faced by China. Curr HIV Res. 2019 Sep 27;: Authors: Zuo L, Peng K, Hu Y, Xu Q Abstract AIDS is a globalized infectious disease. In 2014, UNAIDS launched a global project of "90-90-90" to end HIV epidemic by 2030. The second and third 90 require 90% of HIV-1 infected individuals receive antiretroviral therapy (ART) and durable virological suppression. However, wide use of ART will greatly increase the emergence and spreading of HIV drug resistance and current HIV drug resistance test (DRT) assays in China is seriously lagging behind, hindering to achieve virological suppression. Therefore, recommending an appropriate HIV DRT method is critical for HIV routine surveillance and prevention in China. In this review, we summarized the current existing HIV drug resistance genotypic testing methods around the world, and discussed the advantages and disadvantages of these methods. PMID: 31560290 [PubMed - as supplied by publisher]
Source: Current HIV Research - Category: Infectious Diseases Authors: Tags: Curr HIV Res Source Type: research